Oscar Health (OSCR) Competitors $16.42 -0.33 (-1.97%) As of 05/20/2025 03:58 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OSCR vs. EQH, AEG, EG, BNT, KNSL, GL, BNRE, VOYA, JXN, and ESNTShould you be buying Oscar Health stock or one of its competitors? The main competitors of Oscar Health include Equitable (EQH), Aegon (AEG), Everest Group (EG), Brookfield Wealth Solutions (BNT), Kinsale Capital Group (KNSL), Globe Life (GL), Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), and Essent Group (ESNT). These companies are all part of the "insurance" industry. Oscar Health vs. Equitable Aegon Everest Group Brookfield Wealth Solutions Kinsale Capital Group Globe Life Brookfield Reinsurance Voya Financial Jackson Financial Essent Group Equitable (NYSE:EQH) and Oscar Health (NYSE:OSCR) are both finance companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations, community ranking and profitability. Do institutionals and insiders believe in EQH or OSCR? 92.7% of Equitable shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 1.1% of Equitable shares are held by insiders. Comparatively, 24.4% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor EQH or OSCR? In the previous week, Equitable had 4 more articles in the media than Oscar Health. MarketBeat recorded 22 mentions for Equitable and 18 mentions for Oscar Health. Equitable's average media sentiment score of 1.18 beat Oscar Health's score of 1.18 indicating that Equitable is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Equitable 18 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Oscar Health 12 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate EQH or OSCR? Equitable currently has a consensus target price of $61.83, indicating a potential upside of 15.23%. Oscar Health has a consensus target price of $20.08, indicating a potential upside of 22.31%. Given Oscar Health's higher possible upside, analysts plainly believe Oscar Health is more favorable than Equitable.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Equitable 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92Oscar Health 2 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.29 Does the MarketBeat Community prefer EQH or OSCR? Equitable received 249 more outperform votes than Oscar Health when rated by MarketBeat users. Likewise, 62.17% of users gave Equitable an outperform vote while only 55.22% of users gave Oscar Health an outperform vote. CompanyUnderperformOutperformEquitableOutperform Votes28662.17% Underperform Votes17437.83% Oscar HealthOutperform Votes3755.22% Underperform Votes3044.78% Which has stronger valuation & earnings, EQH or OSCR? Equitable has higher revenue and earnings than Oscar Health. Equitable is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEquitable$14.78B1.10$1.31B$3.6814.58Oscar Health$10.08B0.41$25.43M$0.2858.64 Which has more risk & volatility, EQH or OSCR? Equitable has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, Oscar Health has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Is EQH or OSCR more profitable? Equitable has a net margin of 10.51% compared to Oscar Health's net margin of 0.28%. Equitable's return on equity of 85.70% beat Oscar Health's return on equity.Company Net Margins Return on Equity Return on Assets Equitable10.51% 85.70% 0.69% Oscar Health 0.28%2.28%0.55% SummaryEquitable beats Oscar Health on 15 of the 19 factors compared between the two stocks. Get Oscar Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSCR vs. The Competition Export to ExcelMetricOscar HealthHospital & medical service plans IndustryFinance SectorNYSE ExchangeMarket Cap$4.11B$46.86B$11.64B$19.69BDividend YieldN/A2.00%5.46%3.84%P/E Ratio-820.5919.1622.8435.11Price / Sales0.410.5627.5634.10Price / CashN/A23.1917.6217.51Price / Book4.685.012.854.78Net Income$25.43M$2.21B$1.04B$1.02B7 Day Performance-2.84%4.86%1.44%0.90%1 Month Performance36.75%2.87%8.90%11.10%1 Year Performance-25.36%30.67%539.12%5.28% Oscar Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSCROscar Health2.8553 of 5 stars$16.42-2.0%$20.08+22.3%-25.4%$4.11B$10.08B-820.592,710Positive NewsEQHEquitable4.5415 of 5 stars$53.90+5.0%$61.08+13.3%+32.8%$16.38B$14.78B14.118,200Positive NewsAnalyst ForecastGap UpAEGAegon3.7245 of 5 stars$6.76+0.7%N/A+1.9%$14.89B$19.52B7.0422,300Upcoming EarningsBuyback AnnouncementHigh Trading VolumeEGEverest Group4.8972 of 5 stars$348.35+0.1%$397.18+14.0%-10.8%$14.82B$17.23B11.092,430Positive NewsDividend AnnouncementAnalyst ForecastBNTBrookfield Wealth SolutionsN/A$58.63+3.4%N/AN/A$14.34B$14.34B183.2260KNSLKinsale Capital Group1.5223 of 5 stars$456.70+0.6%$470.00+2.9%+23.8%$10.65B$1.64B25.67470Positive NewsAnalyst ForecastGLGlobe Life4.5604 of 5 stars$120.67-1.0%$137.00+13.5%+42.1%$10.05B$5.84B10.103,540Trending NewsAnalyst ForecastBNREBrookfield ReinsuranceN/A$56.71-2.3%N/A+32.2%$8.25B$9.35B195.5660VOYAVoya Financial4.9569 of 5 stars$69.77+4.2%$81.83+17.3%-6.7%$6.71B$7.83B11.406,000Analyst ForecastJXNJackson Financial4.0777 of 5 stars$86.97+3.0%$91.80+5.5%+11.0%$6.32B$7.20B7.603,500Positive NewsAnalyst ForecastESNTEssent Group4.3582 of 5 stars$59.63+1.9%$61.71+3.5%+5.7%$6.19B$1.27B8.72350Positive News Related Companies and Tools Related Companies EQH Competitors AEG Competitors EG Competitors BNT Competitors KNSL Competitors GL Competitors BNRE Competitors VOYA Competitors JXN Competitors ESNT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OSCR) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oscar Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oscar Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.